RxDoctor Payments Data

James Zaccari, DO

Family Medicine · Brandon, FLNPI 1528133550

Payments from drug & device makers

$7,160in general payments, 2019–2025

Across 403 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$981
  • AbbVie$653
  • Pfizer$594
  • Bayer$516
  • Amarin Pharma, Inc.$451
  • AstraZeneca$451
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$7,154100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,160 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$74,384
Medicare patients
190
Services billed
1,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide134$154,819
RybelsusSemaglutide32$62,002
JardianceEmpagliflozin38$37,618
JanuviaSitagliptin Phosphate41$35,865
EliquisApixaban39$32,803
MounjaroTirzepatide24$26,507
Repatha PushtronexEvolocumab21$16,038
XareltoRivaroxaban12$13,582
VascepaIcosapent Ethyl22$11,797
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,250
Repatha SureclickEvolocumab11$8,241
Atorvastatin Calcium473$4,053
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm12$3,047
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$2,703
Levothyroxine Sodium251$2,653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$981$216,822166 claims
Boehringer IngelheimJardiance$170$37,61838 claims
MerckJanuvia$239$35,86541 claims
PfizerEliquis, Paxlovid$594$34,23353 claims
Lilly USA, LLCMounjaro$199$26,50724 claims
Johnson & JohnsonXarelto$169$13,58212 claims
AstraZenecaBreztri Aerosphere$451$8,25013 claims
AbbVieSynthroid$653$2,12016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →